SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) — Lycia Therapeutics, Inc., a biotechnology company developing lysosomal targeting chimera (LYTAC)-based protein degradation therapies to eliminate disease at its…Read More

You might also be interested in reading What do you think about Monero influencers touting an IRS bounty when, in reality, it was awarded to Chainalysis five years ago?.